France· FR:66375524
LUMOBRY 0,25 mg/mL, collyre en solution
A medicinal product containing tartrate de brimonidine, registered in France by LABORATOIRE CHAUVIN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TARTRATE DE BRIMONIDINE
- Manufacturer
- LABORATOIRE CHAUVIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009302604491 flacon(s) multidose(s) polyéthylène basse densité (PEBD) avec compte-gouttes (incorporé) PEBDL : polyéthylène à basse densité linéaire de 7,5 ml avec fermeture de sécurité enfant
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tartrate de brimonidine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLUMIFY PRESERVATIVE FREE EYE DROPSBausch & Lomb Incorporated
- CzechiaLUMOBRYBAUSCH + LOMB IRELAND LIMITED, Dublin
- FinlandLumobryBausch + Lomb Ireland Limited
- IrelandLumobry 0.25 mg/mL eye drops, solutionBausch + Lomb Ireland Limited
- BelgiumLumobry 0.25 mg/mlBausch + Lomb Ireland
- PolandLumobryBausch+Lomb Ireland Ltd.
- SwedenLumobry 0,25 mg/ml Ögondroppar, lösningBausch + Lomb Ireland Limited
- NetherlandsLumobry 0,25 mg/ml, oogdruppels, oplossingBausch + Lomb Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Alpha-Vision Sine, Alphagan
- Belgium · Alphagan, Lumobry
- Bulgaria · Brimogen, Бримонидин Абр
- Cyprus · Brimontal, Corneax
- Czechia · Alphagan, Brimonidin Olikla
- Germany · Alphagan, Brimo-Vision
- Denmark · Alphagan, Brimonidintartrat 1a Farma
- Spain · Abradel, Alphagan
- Finland · Alphagan, Lumobry
- United Kingdom (Northern Ireland) · Alphagan, Brimonidine Omnivision
- Greece · Alphagan, Brimofree
- Croatia · Alphagan, Bimanox
- Hungary · Brimogen, Lumobry
- Ireland · Alphagan, Lumobry
- Iceland · Alphagan, Brimonidin Bluefish
- Italy · Alphagan, Brimofree
- Liechtenstein · Mirvaso
- Lithuania · Brimonal, Brimonidine Tartrate Elvim
- Luxembourg · Alphagan, Brimonidin Micro Labs
- Latvia · Briglafre, Brimonal
- Malta · Alphagan, Brimogan
- Netherlands · Alphagan, Brimonidine Stulln
- Norway · Alphagan, Brymont
- Poland · Alphagan, Biprolast
- Portugal · Alphagan, Bglau
- Romania · Brimonal 2 Mg/Ml, Brimonidină Rompharm
- Sweden · Alphagan, Brimonidin Bluefish
- Slovenia · Bimanox, Luvify
- Slovakia · Brimonal, Brimonidin Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4cca332c-d26a-48d7-be71-0f145259b836 GET /v1/drugs/4cca332c-d26a-48d7-be71-0f145259b836?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66375524",
"date_amm": "2022-09-15",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "TARTRATE DE BRIMONIDINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tartrate de brimonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.